In particular, our previous studies assessing these biomarkers in saliva samples from Huntington’s disease patients observed detection rates of 100 %, 88.4 %, 81.1 % and 98.9 %, for YKL-40, NfL, GFAP and total tau, respectively [47]. This evidence concerns the gene MAPT and juvenile Huntington disease.